Cargando…

Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature

The disruption of the Hippo pathway occurs in many cancer types and is associated with cancer progression. Herein, we investigated the impact of 32 Hippo genes on overall survival (OS) of cancer patients, by both analysing data from The Cancer Genome Atlas (TCGA) and reviewing the related literature...

Descripción completa

Detalles Bibliográficos
Autores principales: Poma, Anello Marcello, Torregrossa, Liborio, Bruno, Rossella, Basolo, Fulvio, Fontanini, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045671/
https://www.ncbi.nlm.nih.gov/pubmed/30006603
http://dx.doi.org/10.1038/s41598-018-28928-3
_version_ 1783339701994782720
author Poma, Anello Marcello
Torregrossa, Liborio
Bruno, Rossella
Basolo, Fulvio
Fontanini, Gabriella
author_facet Poma, Anello Marcello
Torregrossa, Liborio
Bruno, Rossella
Basolo, Fulvio
Fontanini, Gabriella
author_sort Poma, Anello Marcello
collection PubMed
description The disruption of the Hippo pathway occurs in many cancer types and is associated with cancer progression. Herein, we investigated the impact of 32 Hippo genes on overall survival (OS) of cancer patients, by both analysing data from The Cancer Genome Atlas (TCGA) and reviewing the related literature. mRNA and protein expression data of all solid tumors except pure sarcomas were downloaded from TCGA database. Thirty-two Hippo genes were considered; for each gene, patients were dichotomized based on median expression value. Survival analyses were performed to identify independent predictors, taking into account the main clinical-pathological features affecting OS. Finally, independent predictors were correlated with YAP1 oncoprotein expression. At least one of the Hippo genes is an independent prognostic factor in 12 out of 13 considered tumor datasets. mRNA levels of the independent predictors coherently correlate with YAP1 in glioma, kidney renal clear cell, head and neck, and bladder cancer. Moreover, literature data revealed the association between YAP1 levels and OS in gastric, colorectal, hepatocellular, pancreatic, and lung cancer. Herein, we identified cancers in which Hippo pathway affects OS; these cancers should be candidates for YAP1 inhibitors development and testing.
format Online
Article
Text
id pubmed-6045671
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-60456712018-07-16 Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature Poma, Anello Marcello Torregrossa, Liborio Bruno, Rossella Basolo, Fulvio Fontanini, Gabriella Sci Rep Article The disruption of the Hippo pathway occurs in many cancer types and is associated with cancer progression. Herein, we investigated the impact of 32 Hippo genes on overall survival (OS) of cancer patients, by both analysing data from The Cancer Genome Atlas (TCGA) and reviewing the related literature. mRNA and protein expression data of all solid tumors except pure sarcomas were downloaded from TCGA database. Thirty-two Hippo genes were considered; for each gene, patients were dichotomized based on median expression value. Survival analyses were performed to identify independent predictors, taking into account the main clinical-pathological features affecting OS. Finally, independent predictors were correlated with YAP1 oncoprotein expression. At least one of the Hippo genes is an independent prognostic factor in 12 out of 13 considered tumor datasets. mRNA levels of the independent predictors coherently correlate with YAP1 in glioma, kidney renal clear cell, head and neck, and bladder cancer. Moreover, literature data revealed the association between YAP1 levels and OS in gastric, colorectal, hepatocellular, pancreatic, and lung cancer. Herein, we identified cancers in which Hippo pathway affects OS; these cancers should be candidates for YAP1 inhibitors development and testing. Nature Publishing Group UK 2018-07-13 /pmc/articles/PMC6045671/ /pubmed/30006603 http://dx.doi.org/10.1038/s41598-018-28928-3 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Poma, Anello Marcello
Torregrossa, Liborio
Bruno, Rossella
Basolo, Fulvio
Fontanini, Gabriella
Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature
title Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature
title_full Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature
title_fullStr Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature
title_full_unstemmed Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature
title_short Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature
title_sort hippo pathway affects survival of cancer patients: extensive analysis of tcga data and review of literature
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045671/
https://www.ncbi.nlm.nih.gov/pubmed/30006603
http://dx.doi.org/10.1038/s41598-018-28928-3
work_keys_str_mv AT pomaanellomarcello hippopathwayaffectssurvivalofcancerpatientsextensiveanalysisoftcgadataandreviewofliterature
AT torregrossaliborio hippopathwayaffectssurvivalofcancerpatientsextensiveanalysisoftcgadataandreviewofliterature
AT brunorossella hippopathwayaffectssurvivalofcancerpatientsextensiveanalysisoftcgadataandreviewofliterature
AT basolofulvio hippopathwayaffectssurvivalofcancerpatientsextensiveanalysisoftcgadataandreviewofliterature
AT fontaninigabriella hippopathwayaffectssurvivalofcancerpatientsextensiveanalysisoftcgadataandreviewofliterature